Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study.
Saad A, Goldstein J, Margalit O, Shacham-Shmueli E, Lawrence YR, Yang YX, Reiss KA, Golan T, Mamtani R, Halpern N, Aderka D, Mouallem M, Goldstein A, Giantonio B, Boursi B.
Saad A, et al. Among authors: halpern n.
Pharmacoepidemiol Drug Saf. 2020 May;29(5):599-604. doi: 10.1002/pds.4993. Epub 2020 Mar 20.
Pharmacoepidemiol Drug Saf. 2020.
PMID: 32196836